Research Points to Potential New Treatment for Aggressive Prostate Cancer Subtype
Michigan Medicine - University of MichiganIn two new papers, both published in Cell Reports Medicine, researchers from the University of Michigan Rogel Cancer Center describe聽the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report聽on a promising degrader that targets CDK12 and a related gene to destroy tumors.